Original-Research: EasyMotionSkin Tec AG - von GBC AG
Einstufung von GBC AG zu EasyMotionSkin Tec AG
Unternehmen: EasyMotionSkin Tec AG
ISIN: LI1147158318
Anlass der Studie: Research Comment
Letzte Ratingänderung:
Analyst: Matthias Greiffenberger, Marcel Schaffer
EasyMotionSkin Tec AG is expanding its portfolio with the acquisition of
milongroup, a strategic move that solidifies the company's position in the
healthcare sector. As part of this development, mid-term forecast
adjustments are currently underway.
At an extraordinary general meeting, EasyMotionSkin Tec AG greenlit the
acquisition of milongroup, marking a significant expansion of the company's
offerings in the realm of healthcare solutions. To facilitate this growth,
the company increased its share capital from 1.00 million CHF to 2.92
million CHF. This was achieved through the issuance of 19.20 million new
registered shares, each with a nominal value of 0.10 CHF per share and an
issue price of 5.8325 CHF per share, against a contribution in kind. An
expert report assessed the company value of Milongroup at 111.98 million
CHF. Milongroup, operating in the fitness and healthcare sector, achieved a
revenue of 29.44 million euros in the last fiscal year, with a net profit
of 1.02 million euros. Milongroup is known for its high-quality, highly
digitized fitness equipment in the B2B segment. The integration of
milongroup presents significant growth opportunities through cross-selling,
expanding into new customer segments, internationalization, and
digitization. This strategic move transforms EasyMotionSkin into a holistic
healthcare provider, serving both the B2B and B2C segments and expanding
its product offerings.
Milongroup stands as a leading provider in the professional training
sector, bringing together the brands milon and five. The company offers
comprehensive training solutions to studios and healthcare facilities
worldwide, characterized by innovative equipment and modern methodologies.
The training philosophy is grounded in contemporary sports science and
physiotherapeutic knowledge, delivering an ideal blend of strength and
flexibility training suitable for people of all ages and fitness goals.
This approach enables personalized and effective training for operators,
trainers, and trainees. Furthermore, their electronically controlled
Q-devices are registered as active medical devices and adhere to the
European Medical Device Regulation (MDR), making them suitable for use in
hospitals and clinics.
The strategic move's objective is to establish a comprehensive health
technology conglomerate dedicated to enhancing well-being in various
domains, including physical fitness, agility, health, and the potential
extension of individuals' lifespans.
The acquisition has brought significant changes to the company's outlook
and scale. We anticipate releasing a new mid-term forecast in the near
future.
Die vollständige Analyse können Sie hier downloaden: http://www.more-ir.de/d/27889.pdf
Kontakt für Rückfragen
GBC AG
Halderstraße 27
86150 Augsburg
0821 / 241133 0
research@gbc-ag.de
++++++++++++++++
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG und Art. 20 MAR Beim oben analysierten Unternehmen ist folgender möglicher Interessenkonflikt gegeben: (5a,7,11); Einen Katalog möglicher Interessenkonflikte finden Sie unter:
http://www.gbc-ag.de/de/Offenlegung
+++++++++++++++
Date (time) of completion: 18.10.2023 (19:10)
Date (time) of first distribution: 19.10.2023 (11:00)
-------------------übermittelt durch die EQS Group AG.-------------------
Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
